Biomex GmbH products

The Biomex GmbH CMV IgM Seroconversion Panel consists of 15 members with each member containing 0.5 mL of human plasma. This panel illustrates the onset and decline of IgM and IgG Cytomegalovirus antibodies from one individual over a period of 99 days.

Biomex offers both positive and negative patient samples that are collected in our own donation centers in Munich, Heidelberg and Africa. In addition, we also acquire over 150,000 left-over samples per year from our global network of laboratories. 

Our Seroconversion Panels (SCPs) were developed from non-processed plasma. This was done by collecting plasma from an individual during the evolution of an infection, and the ensuing immunological response. Our seroconversion panels contain defined infection markers and include extensive sample data for comparative analysis. Our SCPs are intended to be used in standard tests by diagnostic manufacturers and researchers during assay development, evaluation, troubleshooting, and post-monitoring of IgM/IgG antibody test systems and methods. In addition, these panels also serve as a validation tool for diagnostic sensitivity, for measuring analytical sensitivity, for identifying cut-off values, or for investigating the humoral immune response to a specific infection.

In order to validate diagnostic specificity for assays that need not be tested according to the comprehensive specifications of the CTS, we also offer a variety of different panels: Cross-reaction panels (RF+, HAMA,...), Inhibition panels (endogenous factors), Negative samples, Hospitalized patient panels, Cross-contamination panels, Serum/Plasma equivalence panels, Blood bank marker panels,

QC release panels (serum and plasma): Positive - low, medium, high range, Negative - no analyte, no virus, no specific antibody, Cut-off - values at range of LoD to clinical decision point